Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2022-000093-25Phase 4Terminated
Phase 4, randomised, double-blind trial of bupivacaine in postoperative pain, perioperative pain and pain (2 arms), sponsored by Aarhus University Hospital. Primary endpoint: Perioperative opioid consumption. Started Jan 2022; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2022-000093-25.